Trial Profile
Use of FERAHEME (Ferumoxytol) for Severe Chronic Kidney Disease and Peritoneal Dialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 12 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 01 Nov 2013 New trial record